Projects

Senior Research Fellow
PharmDr. Silvester Poništ, PhD.

International

Finished
  • Application of bionic hydrogel enriched with selected natural compounds for repair of articular cartilage lesion.
    Program: Bilateral - other
    Duration: 1. 2. 2022 – 31. 12. 2023
  • Anti-inflammatory effects of natural compounds isolated from Vietnam medicinal plants
    Program: Bilateral - other
    Duration: 1. 4. 2020 – 30. 6. 2023
  • Collaboration on a complex pharmacological assessment of inflammatory diseases of the musculo-skeletal system and gastrointestinal tract on experimental animal models
    Program: Bilateral - other
    Duration: 1. 1. 2019 – 31. 12. 2022
  • Anti-inflammatory effect of astaxanthin, sulforaphane and Crocus sativus extract evaluated in two rodent models of age related diseases.
    Program: Inter-academic agreement
    Duration: 1. 1. 2018 – 30. 6. 2021

National

Current
  • Preparation and quality control of modern dosage forms for alternative administration rout of biologics by inhalation (APVV-23-0508)
    Program: SRDA
    Duration: 1. 7. 2024 – 30. 6. 2028
  • Pharmacological intervention in the treatment of cachexia by administering natural extracts (Crocus sativus and Ginkgo biloba) and substances (melittin, saffron, crocin, kaempferol and isorhamnetin) in combination with methotrexate and dexamethasone in an
    Program: VEGA
    Duration: 1. 1. 2023 – 31. 12. 2026
  • The contribution of new nano-carrier drug delivery systems to the enhancement of the anti-inflammatory effect of D-limonene, phellandrene, isoborneol and chrysophanol studied in vivo (2/0091/23)
    Program: VEGA
    Duration: 1. 1. 2023 – 31. 12. 2026
Finished
  • -
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2023
  • -
    Program: Intra-constitutional
    Duration: 1. 1. 2020 – 31. 12. 2022
  • -
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2021
  • -
    Program: SRDA
    Duration: 1. 7. 2016 – 30. 6. 2020
  • -
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2019
  • -
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2018
  • Cellular and molecular aspects of pharmacological regulation of neutrophil pro-inflammatory activity
    Program: SRDA
    Duration: 9. 9. 2008 – 30. 6. 2011
  • Molecular mechanisms of new drugs influencing oxidative stress - important ethiopathogenetic factor of numerous diseases
    Program: SRDA
    Duration: 1. 9. 2006 – 31. 10. 2009
  • Effects of antioxidants and substances afecting the imunita systém studied in vivo using a model of adjuvant arthritis
    Program: VEGA
    Duration: 1. 1. 2005 – 1. 12. 2007
Employees